FDA 483 - Olgam Life LLC - October 29, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Olgam Life LLC, a source plasma establishment in Bronx, NY, revealed three significant observations. The firm failed to consistently follow written standard operating procedures for blood collection, particularly during plasmapheresis. Additionally, the inspection found deficiencies in maintaining quality control and general records, specifically concerning system validation documentation, and noted that equipment used in blood collection was not regularly observed and standardized as required.
ID · 427758c7-db58-4a59-b844-febb3aaace90